Retrieved from GLP-1 Medications and Hair Loss
Journal of Obesity & Metabolic Syndrome, 30 (1), 2031
As long as weight loss has slowed (entering a maintenance phase or losing at a moderate rate), nutritional status is optimized, and no other correctable factors are driving the shedding, hair can recover even while continuing therapy
Given the huge unmet need for new Parkinsons therapies, the new study looks likely to encourage additional studies, at least for GLP-1 compounds that, like lixisenatide, can cross the blood-brain barrier
Plus, he advises many of his patients to use continuous glucose monitors to assess metabolic improvements